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This review summarizes the current knowledge on the role of mitochondria in the context 
of hypoxic cell biology, while providing evidence of how these mechanisms are modu-
lated by methane (CH4). Recent studies have unambiguously confirmed CH4 bioactivity in 
various in vitro and in vivo experimental models and established the possibility that CH4 
can affect many aspects of mitochondrial physiology. To date, no specific binding of CH4 
to any enzymes or receptors have been reported, and it is probable that many of its effects 
are related to physico-chemical properties of the non-polar molecule. (i) Mitochondria 
themselves can be sources of endogenous CH4 generation under oxido-reductive 
stress conditions; chemical inhibition of the mitochondrial electron transport chain with 
site-specific inhibitors leads to increased formation of CH4 in eukaryote cells, in plants, 
and in animals. (ii) Conventionally believed as physiologically inert, studies cited in this 
review demonstrate that exogenous CH4 modulates key events of inflammation. The 
anti-apoptotic effects of exogenously administered CH4 are also recognized, and these 
properties also suggest that CH4-mediated intracellular signaling is closely associated 
with mitochondria. (iii) Mitochondrial substrate oxidation is coupled with the reduction 
of molecular oxygen, thus providing energy for cellular metabolism. Interestingly, recent 
in vivo studies have shown improved basal respiration and modulated mitochondrial oxi-
dative phosphorylation by exogenous CH4. Overall, these data suggest that CH4 liberation 
and effectiveness in eukaryotes are both linked to hypoxic events and redox regulation 
and support the notion that CH4 has therapeutic roles in mammalian pathophysiologies.
Keywords: methane, review, mitochondrion, apoptosis, gasotransmitter
inTRODUCTiOn
Methane (CH4) is a small omnipresent molecule, the simplest alkane, and the most abundant organic 
gas in the atmosphere (1). It can help control the amount of hydroxyl radicals and neutralizes ozone 
in the troposphere (2) and also plays a role in global warming. More importantly, CH4 can be syn-
thesized biologically and several recent studies have revealed its bioactivity. In a pioneering study, 
radioactive 14C-labeled CH4 was administered to the systemic circulation of sheep, and radioactive 
carbon dioxide (CO2) was detected in the breath of animals. Since apart from burning, non-biolog-
ical decomposition of CH4 would need high temperature (above 1,000°C) or catalysts, recovery of 
14CO2 in the exhaled air suggest involvement of CH4 in the cellular metabolism. Unfortunately, the 
underlying mechanisms were never resolved (3). In line with the data of Dougherty and coworkers, 
in a pilot study both 3H- and 14C-labeled CH4 was administered to rats. The subsequent analyses 
revealed organ-dependent rates of retention and decomposition CH4 (4, 5), which was interpreted 
as involvement in the carbon metabolism.
In the past decades, several signaling cascades of small gaseous molecules, including nitric 
oxide (NO), carbon monoxide (CO), and hydrogen sulfide (H2S), have been recognized. These 
gases play vital roles in biological systems, and they are in the focus of research interest (5). Due 
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to its characteristics, availability and effectiveness, CH4 became 
also a candidate gasotransmitter (6). The first reports about the 
protective effect of CH4 against oxidative stress and inflammation 
caused by ischemia and reperfusion (IR) (7, 8) was followed by 
several studies (9–12). Because of its wide-ranging protective 
effects in many diverse disease models, it was proposed that CH4 
could be a new medical gas (13). Indeed, CH4 is intrinsically non-
toxic, without any known side effects. However, before the use in 
human clinical settings, the specific mechanism of action needs 
to be elucidated.
The mitochondrion is feasible target. Mitochondria are spe-
cialized subcellular structures that power various physiological 
roles, such as energy production, reactive oxygen species (ROS) 
formation, calcium homeostasis, and intrinsic apoptosis, all of 
which may be targets of CH4 administration (3, 4). A previous 
review summarized the available findings on the biological role of 
CH4, and it was proposed that CH4 liberation is related to hypoxic 
events resulting in, or associated with mitochondrial dysfunction 
(6). Indeed, several studies have demonstrated that the effects of 
exogenously administered CH4 in IR injuries can be grouped 
around a typical triad, namely anti-inflammatory, anti-oxidative, 
and anti-apoptotic properties. Notably, all these changes are 
also associated with mitochondrial functions, probably via non-
specific physico-chemical alterations of membranes.
Importantly, concentrations of exogenously applied CH4 are 
orders of magnitude higher than those reported for endogenous 
production (reviewed in Section “Endogenous CH4 Formation 
Is Associated with Mitochondrial Dysfunction”). Due to the low 
solubility of CH4 in the watery phase, the majority of the gas is 
exhaled while CH4 is enriched at biological membrane interfaces, 
leading to higher local concentrations. Therefore, no direct con-
clusion can be made about the role of CH4 as a messenger only 
based on studies with CH4 treatment.
Overall, this review summarizes the effects of CH4 on mito-
chondria along with the current knowledge and the best available 
evidences on the possible mode of action. First, mitochondria are 
discussed as sources of endogenous CH4 generation under oxido-
reductive stress conditions. Next, the consequences of exogenous 
CH4 supplementation are outlined: how it modulates key events 
of inflammation that are associated with mitochondrial func-
tions. Thereafter, CH4-mediated intracellular signaling events are 
overviewed that are likely involved in cellular protection. Finally, 
the impact on the mitochondrial substrate oxidation in relation-
ship with the anti-apoptotic effects is discussed.
enDOGenOUS CH4 FORMATiOn iS 
ASSOCiATeD wiTH MiTOCHOnDRiAL 
DYSFUnCTiOn
Mammalian methanogenesis has been considered an exclusive 
attribute of methanogenic Archaea, a group well distinguished 
from bacteria and eukaryotes. Nevertheless, to date, a number of 
studies have demonstrated the generation of non-bacterial CH4 
also in aerobic living systems, and it has also been proposed that 
the CH4-producing phenomenon can be linked to the loss of the 
redox homeostasis.
It was shown in 2003 that hypoxia could lead to the genera-
tion of measurable amounts of non-bacterial CH4 in isolated liver 
mitochondria (14). Increasingly, high amounts of CH4 (between 
0 and 2.3  nmol/mg protein) were generated after the addition 
of ascorbic acid and 1–100  mM hydrogen peroxide (H2O2), 
and the formation of CH4 was related linearly to the quantity of 
mitochondria incubated. A breakthrough came when Keppler 
and colleagues (15) provided direct evidence of CH4 generation 
in multi-cellular organisms under aerobic conditions. This key 
paper was followed by many studies that either supported or 
disagreed with the initial findings (16–19) where the common 
denominator was likely to be mitochondrial dysfunction. More 
importantly, it has been shown that oxido-reductive stress elicits 
aerobic CH4 emission in plants (20).
Interestingly, in 2008, a study by Ghyczy et al. (21) demon-
strated aerobic CH4 emission in cultured endothelial cells exposed 
to hypoxia and metabolic distress. Mitochondrial dysfunction in 
this setting led to significant CH4 generation (~2–23  nmol/mg 
mitochondrial protein), depending on the nature and intensity of 
the metabolic distress, and a similarly high and dose-dependent 
CH4 generation was detected after ROS attack in the Udenfriend 
reaction.
Furthermore, it has been shown that the CH4-producing 
phenomenon can be mimicked by the administration of sodium 
azide (NaN3), a compound known to disrupt mitochondrial 
electron transport flow by specifically binding to cytochrome 
c (Cyt c) oxidase. In this in  vivo study, the whole-body CH4 
production profile was determined in unrestrained animals after 
chronic NaN3 administration (22). In this scenario, the stress-
related methanogenic capacity of the rats was revealed in animals 
treated with antibiotics to eradicate the CH4-producing intestinal 
flora (22). In a model of transient mitochondrial distress, the CH4 
generation of rats and healthy human volunteers was evaluated 
before and after excessive ethanol intake, and significant CH4 
production was demonstrated in both species (23). The phenom-
enon was again independent from the activity of methanogenic 
prokaryotes (23).
The CH4-generating capacity of NaN3 administration 
may also be associated with the generation of ROS (24, 25). 
It has been hypothesized that electrophylic methyl groups of 
biomolecules such as the phosphatidylcholine molecule might 
be carbon precursors (14, 18) and a potential source of CH4 
liberation. Nevertheless, the underlying mechanism is com-
plicated by the various oxido-reductive stress answers of the 
mitochondria, e.g., throughout DNA methylation patterns and 
therefore gene expression changes. Such conditions can both 
affect gene expressions and activity of S-adenosylhomocysteine 
hydrolase (26) and may change the methionine metabolism, 
where CH4 may be liberated as an intermediate compound. 
Recently, Althoff et al. (27) presented a novel chemical reac-
tion that readily forms CH4 from organosulphur compounds 
such as methionine, under highly oxidative conditions, ambi-
ent atmospheric pressure, and temperature. In this reaction, 
methyl sulfides are oxidized to the corresponding sulphoxides 
by a ferryl species, then, in the next phase, demethylation 
of the sulfoxide via homolytic bond cleavage leads to CH4  
formation (27).
FiGURe 1 | Possible signaling pathways involved in the antioxidant, anti-apoptotic, and anti-inflammatory effect of methane. CH4 may induce Nrf2/ARE-mediated 
activation of antioxidant and detoxifying enzymes. These attenuate the excessive production of reactive oxygen species (ROS) resulting preserved mitochondrial 
function as well as anti-inflammatory and anti-apoptotic effects. Second, complementary antioxidant pathways (e.g., FoxO) are also hypothesized to be activated. 
The non-polar nature of CH4 may influence cell membrane permeability and ion channel function-related signal transductionas well. Nrf2, nuclear factor erythroid 
2-related factor 2; ARE, antioxidant response element; HO-1, hem oxygenase-1; SOD, superoxide dismutase; CAT, catalase; γ-GCL, γ-glutamyl cysteine ligase; 
siRNA, small-interfering RNA; FoxO, forkhead box transcription factor class O; CH4, methane; Keap1, kelch-like ECH associating protein 1; NF-κB, nuclear factor 
kappa-light-chain-enhancer of activated B cells; p65, transcription factor p65.
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nOveL SiGnALinG PATHwAYS invOLveD 
in CH4-MeDiATeD nUCLeAR AnD 
MiTOCHOnDRiAL eFFeCTS
CH4 might alter the pattern of the activation of various signal 
transduction pathways and vice versa, the well-described triple 
effect (i.e., anti-inflammatory, antioxidant, and anti-apoptotic) of 
CH4 may influence the upregulation and downregulation of cellu-
lar signaling cascades. A direct link between exogenously admin-
istered CH4 and signaling targets have been reported recently 
(28, 29); however, a crosstalk with other bioactive gases and path-
ways cannot be excluded. Furthermore, no specific binding of 
CH4 to any enzymes or receptors have been reported to date, and 
it is highly probable that many (if not all) of its effects are related 
to physico-chemical properties of the non-polar molecule.
In a recent study by Wang et  al. (29, 30), a supersaturated 
(~1.5  mmol/l) CH4-enriched saline solution was administered 
in a rat model of IR injury. High tissue concentrations of CH4 
(between 90 and 145  µmol/g) were achieved, which lead to 
increased expression of Nrf2 (also known as nuclear factor eryth-
roid 2-related factor 2). Nrf2 undoubtedly plays a central role in 
the activation of antioxidant defense system in most living organ-
isms. It is now well characterized that Nrf2 translocates and binds 
to the antioxidant response element (ARE) forming a complex 
in the nucleus and induces the expression genes antioxidant and 
detoxifying enzymes (Figure 1) (31, 32). A negative regulator of 
Nrf2–ARE pathway is the kelch-like ECH associating protein 1 
(Keap1), which forms a cytoplasmic complex with Nrf2 and inhib-
its its translocation to the nucleus under basal conditions (33).
Wang and coworkers (29, 30) have found that CH4 administra-
tion enhances Nrf2 expression at both the mRNA and protein 
levels. In this study, marked elevations in Nrf2 mRNA and 
protein levels were found while the regulatory Keap1 protein 
was degraded in a time dependent manner. Besides, activation of 
phosphatidylinositol 3-kinase–Akt pathway, an indirect mecha-
nism involved in the synergistic activation of Nrf2–ARE oxida-
tive stress response, may also play a role in CH4 action (28, 34). 
As a result of CH4-upregulated Nrf2/ARE signaling, activated 
downstream enzymes [e.g., hem oxygenase-1, superoxide dis-
mutase (SOD), catalase, and γ-glutamyl cysteine ligase] attenuate 
the excessive production of ROS and result in preserved mito-
chondrial function (35) as well as anti-inflammatory (36–38) and 
anti-apoptotic effects (39, 40).
Among several transduction pathways, the forkhead box 
transcription factor class O (FoxO)-related antioxidant enzyme 
induction seems to be a novel candidate in the protective effects of 
CH4 (41). Although FoxO in cooperation with tumor suppressor 
p53 (42) regulates cell cycle arrest, it is also responsible for ROS 
elimination by promoting the expression of numerous antioxi-
dant genes and detoxifying enzymes (43); such as SOD, catalase, 
glutathione peroxidase 2, glutathione-S-transferase, and a sulfire-
doxin (42). Moreover, it may influence mitochondrial homeo-
stasis (44) through the modulation a serine/threonine-protein 
kinase, PTEN-induced putative kinase, thereby contributing to 
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cell survival. Nevertheless, in the absence of data confirming that 
CH4 acts on FoxO pathway (45) in animal disease models, this 
remains only a hypothesis.
CH4-MeDiATeD ACTiOnS On THe 
MiTOCHOnDRiAL eLeCTROn 
TRAnSPORT SYSTeM (eTS)
CH4 has favorable distribution characteristics by penetrating mem-
branes and diffusing into organelles including mitochondria (46); 
therefore, a potential effect of CH4 on the mitochondrial respiration 
has also been emerged. Upon exogenous administration, CH4 gets 
into the bloodstream through the alveoli of the lung and dissolves 
in the plasma. The cytoplasm/plasma solubility is near uniform for 
CH4; however, this ratio is much higher in hydrophobic substances 
such as the phospholipid biomembranes of mitochondria (47, 48). 
Of interest, the protein complexes of the mitochondrial respiratory 
chain are partially embedded in the inner mitochondrial mem-
brane, exposing parts of them to the hydrophobic lipid bilayer, 
which makes them potential targets of the CH4.
The modulator effects of small gaseous molecules on mito-
chondrial respiration have been demonstrated in animal models 
of IR injury both in vivo and in hypoxic assays in vitro (11, 30, 
49–51). Specifically, NO exerted protection through the activation 
of the mitochondrial KATP channel opening (50) and induced a 
sustained mitochondrial depolarization (49). H2S preserved mito-
chondrial membrane integrity and the complex I- and II-linked 
oxygen consumption rate (51). CH4 restored the ADP-dependent 
mitochondrial respiration, i.e., the oxydative phosphorylation 
(11, 30). During oxygen deprivation, the mitochondrial ETS is 
manifested lower rates of non-phosphorylating basal respiration. 
In addition, the ADP-dependent oxygen consumption, or in 
other words oxidative phosphorylation, is significantly depressed. 
In contrast, reperfusion conditions induce leakage of electrons 
from the ETS into the intermembranous space (52) that leads to 
increased ROS formation. These results suggest the sensitivity of 
both the resting state of ETS and the mitochondrial bioenergetic 
function to IR injury.
General effects of CH4 on IR-related mitochondrial dysfunc-
tion involve the restoration of the electron transport machinery 
of the inner mitochondrial membrane when oxygen concentra-
tion rises. In a study by Strifler et al. (11), mitochondria incubated 
in a medium with a gas phase containing 2.2% CH4–air mixture 
displayed a significantly improved leak respiration and increased 
recovery of oxidative phosphorylation. These effects of CH4 on the 
inner mitochondrial membrane can be explained with a hypoth-
esis which presumes that CH4 dissolves in biological membranes 
thereby changing its oxidative stress-related rigidity (7).
In parallel with the general effects on the mitochondrial ETS, 
CH4 seems to exert site-specific action on protein complexes. 
Among the protein complexes of the mitochondrial ETS, com-
plex IV (cytochrome c oxidase), which catalyzes the reduction of 
oxygen by ferrycytochrome to H2O, is target of the CH4 action. 
Indeed, endogenous CH4 generation occurs in plant mitochon-
dria (53) and in mammalian cells after inhibition of complex IV 
by NaN3 (22). Meanwhile, exogenous CH4 administration in IR 
injury conditions resulted in reduced Cyt c release from the inner 
mitochondrial membrane and lower Cyt c oxidase activity in liver 
mitochondria (11).
Nonetheless, the above observations are all related to the in vivo 
effects of exogenous CH4 supplementation on mitochondria in 
oxido-reductive stress conditions. Interestingly, direct mitochon-
drial effects could not be shown when a 2.2% CH4–air mixture was 
administered isolated mitochondria in vitro (11). In other words, 
direct effect of CH4 on oxidative phosphorylation capacity and leak 
respiration in intact liver mitochondria cannot be shown in vitro. 
CH4 has relatively low solubility in watery phase, ranging from 
37.2 to 19.1 mg/l between 0 and 35°C at 1 standard atmosphere. 
Therefore, high concentrations should be applied exogenously 
to overcome the limitation of low gas solubility. This means that 
approximately 1 mmol/l/min CH4 was usually applied as gas therapy 
(7) and 1.6 mmol/l in CH4-enriched saline (29). Consequently, CH4 
concentrations in tissues upon CH4 treatment are certainly higher 
than the average endogenous levels. Still, due to the high affinity 
of Cyt c oxidase for oxygen (54), CH4 does not dysproportionate 
oxygen and thus does not limit mitochondrial respiration.
CH4-MeDiATeD ACTiOnS On APOPTOSiS
The anti-apoptotic effect is one of the most studied properties 
of CH4. Several studies demonstrated that CH4 modulates the 
intrinsic pathway of apoptosis (9–11, 29, 30, 55–58). The intrin-
sic pathway of apoptosis, also called the mitochondrial pathway 
owing to the essential involvement of mitochondria (59), which 
are not only the site where anti- and pro-apoptotic proteins 
interact but also the origins of high range of signal pathways that 
initiate the activation of caspases through various mechanisms 
(60). The large family of Bcl-2 homologs involves key proteins 
of intrinsic apoptosis described to organize the process (61). 
They can be divided into two classes: anti-apoptotic Bcl-2 family 
proteins (such as Bcl-XL, Bcl-w, Mcl-1, A1, Bcl-Rambo, Bcl-L10, 
and Bcl-G) and pro-apoptotic proteins [such as Bcl-2 associated 
X protein (Bax), Bak, and Bok] (62). The primary anti-apoptotic 
function of Bcl-2 is to block the release of Cyt c. In contrast, upon 
stress, pro-apoptotic members of the Bcl-2 family are activated 
(Bak or Bax) which leads to the mitochondrial outer membrane 
permeabilization and subsequent release of intermembrane space 
proteins such as Cyt c. Cyt c is attached to the inner mitochon-
drial membrane and shuttles electrons between complex III and 
complex IV. In response to membrane damage, it releases to the 
cytosol and activate the initiator procaspase-9 within the apop-
totic protease-activating factor-1 (Apaf-1) apoptosome complex 
(63). Once activated, caspase-9 activates effector procaspase-3 
which, in turn, can cleave various protein substrates, leading to 
the morphological and biochemical features of apoptosis (64).
In IR, CH4 supplementation may improve the level of key 
regulators of apoptosis, such as Bcl-2, Apaf-1, and caspases 
indirectly through an unknown pathway (10). Two recent studies 
of experimental retinal IR provided evidence for the effective-
ness of CH4 treatment on upregulation of anti-apoptotic Bcl-2 
proteins, while reduced cleaved caspase 3- and 9 quantities 
(10, 57). Likewise, in an experimental spinal cord IR scenario, CH4 
was proven to significantly reduce the number of apoptotic cells 
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FiGURe 2 | The anti-apoptotic effect of CH4. The release of cytochrome c and other inner mitochondrial membrane proteins are regulated by Bcl-2 family proteins 
through interplay between pro-apoptotic and anti-apoptotic proteins, which converge to Bax/Bak activation, thereby inducing mitochondrial outer membrane 
permeability. CH4, methane; CLDN6, claudin 6; RIP 1, receptor-interacting kinase 1; ASK-1, apoptosis signal-regulating kinase 1; p-38, mitogen-activated protein 
kinase; Casp-3, caspase 3; Casp-9, caspase 9; Apaf-1, apoptotic protease-activating factor 1; Hrk/DP5, harakiri gene; Bcl-2, B-cell lymphoma 2 regulation protein; 
JNK, c-Jun N-terminal kinase; BAX, Bcl-2 associated X protein; BAK, Bcl-2 homologous antagonist/killer.
(confirmed by TUNEL staining) and also the amount of cleaved 
caspase-3 and caspase-9 proteins and to attenuate cytosolic Cyt c 
release (29). In addition, CH4-rich fluids significantly reduced the 
expression of cleaved caspase-3 and also decreased the apoptotic 
cell number in rodents exposed to LPS-induced acute lung injury 
(58). In a hepatic IR model, CH4 inhalation could effectively 
attenuate the apoptosis-linked morphological changes in the 
liver and the TUNEL positivity of hepatocytes (11). Similarly, cas-
pase-3 expression was attenuated with CH4-rich saline treatment 
which substantiated this finding (56). Moreover, CH4-rich saline 
has pronounced neuroprotective effect in diabetic retinopathy 
in streptozotocin-induced diabetes, possibly by upregulating 
those cell cycle related microRNAs, which contribute to post-
transcriptional regulation (65). A possible indirect way how CH4 
supplementation modulates apoptosis is to reduce the level of 
mitochondrial ROS formation. ROS and their by-products can 
oxidize the reduced thioredoxin-apoptosis signal-regulating 
kinase 1 complex, then activate apoptosis signal-regulating kinase 
and its downstream stress signaling targets, such as c-Jun NH(2)-
terminal kinase (66). Another plausible explanation for the anti-
apoptotic effect of CH4 is reducing Cyt c release from the inner 
membrane, which has already been demonstrated in hepatic, 
myocardial, and spinal cord IR as well (9, 11, 29) (Figure 2).
PeRSPeCTiveS AnD COnCLUDinG 
STATeMenTS
In the human body, many gases are biologically active. Signaling 
roles were demonstrated for NO, CO, and H2S, and it has become 
clear that gaseous mediators form complex intracellular pathways 
and regulate numerous physiological processes, separately, or more 
often, in antagonistic or synergistic ways. CH4 is a small, less reac-
tive gas molecule, having a close symbiosis with bioactive gases in 
the intracellular spaces. The effects of exogenous CH4 were clearly 
illustrated in detail in various tissues under different conditions. Of 
particular interest is that the recognized biological effects of CH4 
are not cell- or tissue specific, and an increased input may result in 
anti-inflammatory changes in cells and tissues. In this regard, it is 
tempting to speculate on a much broader, controller role for CH4 
in acute and chronic oxido-reductive stress conditions.
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